Hopp til innholdet
innsidehandel

← Alle transaksjoner

Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider

Nykode Therapeutics ASA (NYKD) · publisert 21. mars 2024 kl. 19:38 · vis på NewsWeb

Transaksjoner

PersonRolleTypeVolumPrisDatoISINHandelsplass
Birgitte Volck Kjøp20 31115,276 NOK21. mars 2024NO0010714785XOSL - Oslo Stock Exchange

Vedlegg

Meldingstekst

Oslo, Norway, March 21, 2024 - Primary insider Birgitte Volck, Member of the Board of Directors of Nykode Therapeutics ASA, has today acquired 20,311 shares in Nykode Therapeutics ASA at an average price of NOK 15.276 per share. Please see further details in the attached document.